IFI-M · SK Precision Dual-Axis Series

Specimen SS-F-M2-08052 // MULTI-AXIS · IFI-M

SK Precision Dual-Axis Series I-IV-C

Stevia rebaudiana

Stevia

Tier ISK Precision Dual-Axis Series

Target Trait

1.88×

fold-change

Sweet+Kokumi precision dual-axis IFI score

Technical Specifications

SKU

SS-F-M2-08052

Genomic Edits

8

GC Content

44.6%

Construct Length

4,355 bp

Promoter System

T7/SP6 cell-free

Expression System

In-vitro cell-free

Host Strain

Cell-free

Receptor Target

TAS1R2/TAS1R3 + CaSR

IFI Score

188

Pathway Edits

  • TAS1R2/TAS1R3 pathway primary gene cluster overexpression for sweet axis activation
  • CaSR pathway primary gene cluster overexpression for kokumi axis activation
  • Bidirectional promoter system for synchronized S+K dual-axis co-expression
  • Metabolic flux partitioning between IFI-S and IFI-K pathway branches via carbon flow optimization
  • Transcription factor co-binding site engineering for Sweet-Kokumi combinatorial gene regulation
  • Cross-pathway feedback inhibition circuit removal for S+K simultaneous accumulation
  • Tissue-specific expression cassette deployment for optimized SK spatial patterning
  • Chassis organism metabolic engineering for SK dual-output receptor target optimization

Key Interventions

Dual-receptor co-activation via synchronized TAS1R2/TAS1R3 and CaSR pathway engineeringMetabolic flux partitioning strategy enabling simultaneous sweet and kokumi accumulation without competing pathway suppressionPrecision combinatorial regulation for SK multi-axis integrationCell-free co-translation of multi-axis enzyme sets for in-vitro biochemical validation

IFI Subscale Profile

IFI Profile

IFI-S
—
IFI-U
—
IFI-B
—
IFI-K
—
IFI-C
—
IFI-P
—
IFI-A
—
IFI-F
—

Use Case

Tier I SK dual-axis precision dual platform for food ingredient applications requiring verified combined sweet+kokumi sensory character. Suitable for multi-modal flavor architecture, premium ingredient certification, and receptor-confirmed IFI multi-axis profiling.

License

$449 · Tier I License

Includes full construct sequence, CRISPR guide designs, pathway edit specifications, flux balance analysis, and IFI validation data.

Already purchased?

Back to Multi-Axis · IFI-MAll Modalities